课题基金 / 基金详情

项目摘要

项目成果

PETER Justin TODD的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):药用蛋白质构成了制药市场的一个巨大且快速增长的部分。为了安全和有效,药物蛋白质不仅必须具有正确的共价结构,还必须具有正确的非共价三维折叠结构-并且没有能够在质量保证(QA)的基础上保证这种构象完整性的现有方法。一种被称为羟基自由基蛋白足迹(HRFP)的技术已经被描述用于重组药物蛋白与FDA批准的制剂的严格结构比较。HRFP使用短寿命羟基(OH)的爆发。这些基团与蛋白质表面上的氨基酸反应,产生易于通过液相色谱-质谱联用(LCMS)识别的修饰。对于QA,蛋白质供试品的HRFP结果必须与蛋白质标准品的HRFP结果相匹配。否则,测试样品的结构已受损。在观察到标准品和样品之间存在差异的情况下,可以确定这些异常的大致位置,从而有助于故障排除。虽然该方法作为一种分析和质量保证工具具有很强的潜力,但HRFP需要相当程度的高度专业化的专门知识来生成足够可靠的数据,以用作质量保证方法。我们提出了一个自动化的平台来执行整个HRFP流程。实际上,该平台将被插入到现有的自下而上的质谱蛋白质分析自动化工作流程中。我们建议生产一个自动化的样品处理和闪光光解系统,闪光光解产生的羟基自由基的替代方案,HRFP的每个步骤的QA监视器,和统计质量保证计算机程序。我们将展示集成系统检测当前药物蛋白质结构异常的能力。由此产生的系统将是一个单一供应商的自动化HRFP平台,用于插入现有的LCMS系统,允许具有蛋白质质谱专业知识的研究人员应用该技术。
英文摘要
DESCRIPTION (provided by applicant): Pharmaceutical proteins comprise a large and rapidly growing segment of the pharmaceutical market. To be safe and effective, pharmaceutical proteins must possess not only the correct covalent structure, but also the correct non-covalent three-dimensional folded structure - and there is no existing method capable of guaranteeing this conformational integrity on a quality assurance (QA) basis. A technology known as hydroxyl radical protein footprinting (HRFP) has been described for the rigorous structural comparison of recombinant pharmaceutical proteins with FDA-approved formulations. HRFP uses a burst of short-lived hydroxyl (OH.) radicals to react with amino acids on the protein surface, creating modifications easily recognized by liquid chromatography coupled to mass spectrometry (LCMS). For QA, results of HRFP from a test sample of a protein must match HRFP results from the protein standard. Otherwise, the structure of the test sample has been compromised. In cases where differences between standard and sample are observed, the general location of these abnormalities can be determined, aiding in troubleshooting. While the method exhibits strong potential as an analytical and QA tool, HRFP requires a substantial degree of highly specialized expertise to generate data sufficiently reliable for use as a QA method. We propose an automated platform for executing the entire HRFP process. Practically, and philosophically, the platform will be inserted into the existing automated workflow of bottom-up protein analysis by mass spectrometry. We propose to produce an automated sample handling and flash photolysis system, alternate schemes for flash photolytic generation of hydroxyl radicals, QA monitors for each step of HRFP, and statistical quality assurance computer programs. We will demonstrate the ability of the integrated system to detect structural abnormalities with current pharmaceutical proteins. The resulting system will be a single-vendor automated HRFP platform for insertion into already-existing LCMS systems allowing application of this technology by researchers with a conventional level of expertise in protein mass spectrometry.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ORGANIC SECONDARY ION IMAGING
ORGANIC SECONDARY ION IMAGING
ORGANIC SECONDARY ION IMAGING
ORGANIC SECONDARY ION IMAGING
海外基金